Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
41.8 USD | -0.30% | -1.55% | -30.07% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-30.07% | 5.09B | |
+0.10% | 91.42B | |
+3.16% | 41.08B | |
-11.36% | 34.26B | |
+53.99% | 25.27B | |
-9.59% | 12.81B | |
-12.25% | 11.6B | |
-44.00% | 11.42B | |
+5.77% | 9.16B | |
-6.90% | 8.22B |
- Stock Market
- Equities
- APLS Stock
- News Apellis Pharmaceuticals, Inc.
- UBS Adjusts Apellis Pharmaceuticals Price Target to $87 From $70, Maintains Buy Rating